Skin preparation for external use characterized by containing sugar derivative of α, α-trehalose
View Patent ↗The present invention has an object to provide an external dermatological formulation having satisfactory blood flow-promoting effect, antiinflammatory effect, antibacterial effect, moisturizing effect, whitening effect, UV-absorbing effect, UV-scattering effect, antioxidant effect, hair growing effect, hair nourishing effect, emusifying effect, astringent effect, wrinkle-reducing effect, cell-activating effect and/or transdermal absorption-promoting effect with a satisfactory safety and skin feeling; The object is solved by providing an external dermatological formulation comprising a saccharide derivative of α,α-trehalose and one or more members selected from substances having any one of blood flow-promoting effect, antiinflammatory effect, antibacterial effect, moisturizing effect, whitening effect, UV-absorbing effect, UV-scattering effect, antioxidant effect, hair growing efect, hair nourishing effect, emulsifying effect, astringent effect, wrinkle-reducing effect, cell-activating effect and transdermal absorption-promoting effect.
1. An external dermatological formulation adapted for application to skin, wherein the formulation comprises
(A) a saccharide composition, which saccharide composition comprises, on a dry solid basis,
(1) 50 to 70% of α-maltosyl α,α-trehalose,
(2) 5 to 25% of total other saccharide derivatives of α,α-trehalose, and
(3) 25 to 45% of sugar alcohols selected from the group consisting of sorbitol and sugar alcohols of maltooligosaccharides,
(B) hyaluronic acid in a moisturizing effective amount, and
(C) an amount sufficient to promote blood flow of sialid extract,
whereby the external dermatological formulation has improved blood flow promoting effect of the sialid extract.
2. A process for making the external dermatological formulation of claim 1 , which comprises incorporating said saccharide composition in an external dermatological formulation containing hyarulonic acid and sialid extract.
3. The external dermatological composition according to claim 1 , wherein the saccharide composition is present in an amount of from 0.001 to 50% of the total dermatological compositions.
4. The external dermatological composition according to claim 3 , wherein the saccharide composition is present in an amount of from 0.1 to 40% of the total dermatological composition.